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Edited by Gianni CesareniAbstract Diacylglycerol kinase (DGK)c was shown to act as an
upstream suppressor of Rac1. Here we report that, in COS7 cells
stimulated with epidermal growth factor (EGF), DGKc speciﬁ-
cally interacts and co-localizes at the plasma membrane with
b2-chimaerin, a GTPase-activating protein (GAP) for Rac.
Moreover, DGKc enhanced EGF-dependent translocation of
b2-chimaerin to the plasma membrane. Interestingly, DGKc
markedly augmented EGF-dependent GAP activity of b2-chima-
erin through its catalytic action. These results indicate that
DGKc is a novel regulator of b2-chimaerin, and thus suggest that
b2-chimaerin is an eﬀector molecule, linking DGKc functionally
with Rac1.
 2007 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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It is well recognized that a variety of lipid second messengers
in low abundance carry out speciﬁc tasks for a wide range of
biological processes in eukaryotic cells. The cellular concentra-
tions of such signaling lipids must be strictly regulated by the
action of metabolic enzymes. Diacylglycerol (DAG) kinase
(DGK) phosphorylates DAG to yield phosphatidic acid (PA)
[1–3]. DAG is an established activator of conventional and
novel protein kinase Cs (PKCs), Unc-13 and Ras guanyl
nucleotide-releasing protein [4,5]. PA has also been reported
to regulate a number of signaling proteins such as phosphati-
dylinositol-4-phosphate 5-kinase (PIP5K), Ras GTPase-acti-
vating protein, Raf-1 kinase and atypical PKC [2,3,6,7]. In
this context, it is of interest to note that chimaerin, a Rac-
speciﬁc GTPase activating protein (GAP), is activated by both
DAG [4,5,8] and PA [9,10].Abbreviations: DGK, diacylglycerol kinase; DAG, diacylglycerol; PA,
phosphatidic acid; PKC, protein kinase C; PIP5K, phosphatidylino-
sitol-4-phosphate 5-kinase; EGF, epidermal growth factor; GAP,
GTPase-activating protein; GFP, green ﬂuorescent protein; EGFP,
enhanced GFP; ECFP, enhanced cyan ﬂuorescent protein; PDGF,
platelet-derived growth factor; RT, reverse transcriptase; GST, gluta-
thione S-transferase; PBD, p21-binding domain; PAK, p21 activated
kinase; siRNA, small interfering RNA; WT, wild-type
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doi:10.1016/j.febslet.2007.01.022Mammalian DGK is known to exist as a large protein family
consisting of 10 isozymes classiﬁed into ﬁve subtypes according
to their structural features [1–3]. The type I DGKs consisting
of a, b, and c-isozymes contain two sets of Ca2+-binding EF-
hand motifs at their N-termini. The tissue- and cell-dependent
expression patterns detected distinctively for these isozymes
suggest that, even belonging to the same subfamily, each mem-
ber exerts diﬀerentiated functions in particular types of cells.
Moreover, we already reported that the EF-hand motifs of
the type I DGKs have properties distinct from each other with
respect to aﬃnities for Ca2+ and to Ca2+-induced conforma-
tional changes [11].
Rac1 is a member of the Rho small GTPase family together
with RhoA and Cdc42. The active form of Rac1 interacts with
various eﬀectors to initiate downstream signaling events that
control cell morphology, actin dynamics, migration, meta-
stasis, gene expression, apoptosis and cell cycle [12,13]. Rac
GTPase is known to act as a molecular switch, cycling between
an active GTP-bound state (Rac-GTP) and an inactive GDP-
bound state (Rac-GDP). This switch is regulated by the three
groups of eﬀector molecules: guanine nucleotide exchange fac-
tors, guanine nucleotide dissociation inhibitors, and GAPs.
While there is a signiﬁcant redundancy in the speciﬁcities of
Rho GAPs at least in vitro, chimaerin possesses speciﬁcity to-
ward Rac, and it does not accelerate GTP hydrolysis for either
RhoA or Cdc42 in vitro and in vivo [4,5,14]. Chimaerin com-
prises a family of four isoforms (a1- or ‘n’-, a2-, b1- and b2-
chimaerins), which are splice variants of the a- and b-chima-
erin genes. The common structural feature among all chimae-
rins is, in addition to the GAP domain, the presence of the C1
domain that was ﬁrst found in PKC [4,5]. Although these
chimaerin Rac-GAPs are activated in response to several cell
stimuli [4,5,14], their activation mechanisms are not fully
understood.
We previously reported that DGKc acts as an upstream sup-
pressor of Rac1, but not Cdc42 [15]. However, eﬀector mole-
cules that mediate the function of DGKc remain unclear. In
the present study, we report that DGKc speciﬁcally interacts
with and activates b2-chimaerin in response to cell stimulation
with epidermal growth factor (EGF) and propose that b2-
chimaerin is an eﬀector molecule operating between DGKc
and Rac1.2. Materials and methods
2.1. Materials
Anti-DGKc polyclonal antibody was generated as described
previously [16]. Other antibodies were obtained from commercialblished by Elsevier B.V. All rights reserved.
552 S. Yasuda et al. / FEBS Letters 581 (2007) 551–557sources as follows: anti-FLAG M2 (Sigma-Aldrich, St. Louis,
MO), anti-c-myc (9E10, Roche, Indianapolis, IN), anti-green ﬂuo-
rescent protein (GFP) (B-2, Santa Cruz Biotechnology, Santa
Cruz, CA), anti-GFP polyclonal antibody (Takara-Clontech, Tokyo,
Japan), and anti-Rac1 (23A8, Upstate Biotechnology, Lake Placid,
NY). Platelet-derived growth factor (PDGF)-BB was from Sigma-
Aldrich. EGF was from Wako Pure Chemical Industries (Osaka,
Japan).
2.2. Plasmid constructs
The cDNA coding for human DGKc [17] was ampliﬁed by PCR and
inserted into the Hind III–Xho I site of pCMV-Tag3B (Stratagene, La
Jolla, CA) for N-terminal c-myc tagging. pEGFP (enhanced GFP)-
DGKc, pEGFP-DGKc-G494D (a kinase-dead mutant) and
p3 · FLAG-DGKc were generated as described previously [18]. To
generate p3 · FLAG-a1-, a2-, and b2-chimaerins, a1-, a2- and b2-
chimaerin cDNAs were ampliﬁed by PCR from human brain
QUICK-clone cDNA (Takara-Clontech) using the following primers:
a1-chimaerin, 5 0-CCGAATTCAATGAAACTGGTTCTCCAAAG-
TC-3 0 and 5 0-CCGTCGACTTAAAATAAATGTCTTCGTTTTTGA-
TAAGC-30; a2-chimaerin, 5 0-TTCGAATTCTATGGCCCTGAC-
CCTGTTTG-3 0 and 5 0-TACCGTCGACTTAAAATAAAATGTCT-
TCGTTTTTG-3 0; b2-chimaerin, 5 0-CCGAATTCGATGGCAGCGT-
CCAGCAACTCC-3 0 and 5 0-CCGTCGACGGATTAGAATAAAA-
CGTCTTCGTTTC-3 0. The PCR fragments of a1-, a2- and b2-chimae-
rins were digested with EcoRI and SalI and inserted into p3 · FLAG-
CMV-7.1 (Sigma-Aldrich). To construct pECFP (enhanced cyan ﬂuo-
rescent protein)-b2-chimaerin and pDsRed-monomer-b2-chimaerin,
an EcoRI–SalI cut fragment of p3 · FLAG-b2-chimaerin was inserted
into pECFP-C1 and pDsRed-monomer-C1 (Takara-Clontech), respec-
tively. The authenticity of the constructs was conﬁrmed by DNA
sequencing.2.3. Cell culture and transfections
NIH3T3 and COS7 cells were maintained in Dulbecco’s modiﬁed
Eagle’s medium (Sigma-Aldrich) containing 10% fetal bovine serum
at 37 C in an atmosphere containing 5% CO2. NIH3T3 cells
(1 · 106 cells per 60-mm dish) were transfected with 10 nM RNA oli-
gonucleotides (see Section 2.4) using HiPerFect (QIAGEN, Tokyo)
according to the instructions from the manufacturer. After 48 h, cells
were serum-starved for 5 h in Dulbecco’s modiﬁed Eagle’s medium
containing 0.1% bovine serum albumin and stimulated with 50 ng/ml
PDGF-BB for 5 min. COS7 cells (1 · 106 cells per 60-mm dish) were
transiently transfected with plasmids (1 lg) using Eﬀectene (QIAGEN)
according to the instructions from the manufacturer. After 24 h, cells
were serum-starved for 5–15 h in Dulbecco’s modiﬁed Eagle’s medium
containing 0.1% bovine serum albumin and stimulated with 100 ng/ml
EGF for 2–10 min.2.4. RNA interference and reverse transcriptase (RT)-PCR
To silence the expression of mouse DGKc (GenBank Accession No.
NM138650) and b2-chimaerin (GenBank Accession No. AK131641),
the following RNA oligonucleotides (iGENE Therapeutics, Tsukuba,
Japan) were used: DGKc, sense: 5 0-UGUGUGAAAACAAACUC-
CAAAGCCAAG-3 0, antisense: 5 0-UGGCUUUGGAGUUUGUUU-
UCACACAAU-3 0; b2-chimaerin, sense: 5 0-UGAGCAGGUCUAA-
AAACGAAUCAAGAG-3 0, antisense: 5 0-CUUGAUUCGUUUUU-
AGACCUGCUCAAU-30; EGFP (control), sense: 5 0-ACGGCAU-
CAAGGUGAACUUCAAGAUAG-30, antisense: 5 0-AUCUUGAA-
GUUCACCUUGAUGCCGUAU-30. The annealed oligonucleotide
duplex, small interfering RNA (siRNA), was transfected as described
above (see Section 2.3).
Isolation of total RNA and reverse-transcription were performed as
described previously [15]. The synthesized cDNA was ampliﬁed with
TaKaRa Ex Taq (Takara). PCR conditions were as follows: 94 C
for 1 min; 25 cycles (b-actin) or 35 cycles (DGKc and b2-chimaerin)
at 94 C for 30 s, 60 C for 30 s, and 72 C for 1 min; and 72 C for
3 min. Sequences of PCR primers were as follows: DGKc, 5 0-TCAA-
GAAGCCCACTTACTGCAAC-3 0 and 5 0-CATTTGCGGTGAAA-
CGTCATC-30; b2-chimaerin, 5 0-CTGCTGAGTACATCGCGAAA-
ATGAC-30 and 5 0-ATGTGTGCACCTTGAAGTTGTGTG-3 0; b-
actin, 5 0-GGGAAATCGTGCGTGACAT-30 and 5 0-ACATCTGCT-
GGAAGGTGGACAG-30. PCR products were analyzed by agarose
gel electrophoresis and stained with ethidium bromide.2.5. Aﬃnity precipitation of activated Rac1
NIH3T3 cells were transfected with siRNA targeting EGFP (con-
trol), DGKc or b2-chimaerin. After 48 h of transfection, cells were ser-
um-starved for 5 h and stimulated with 50 ng/ml PDGF-BB for 5 min.
COS7 cells were transfected with p3 · FLAG-b2-chimaerin and either
pEGFP, pEGFP-DGKc-WT (wild-type) or pEGFP-DGKc-G494D.
After 24 h, cells were serum-starved for 5 h and incubated with or with-
out 100 ng/ml EGF for 10 min. NIH3T3 and COS7 cells were lysed in
500 ll of ice-cold buﬀer A (25 mM Tris–HCl, pH7.5, 150 mM NaCl,
5 mM MgCl2, 1% Nonidet P-40, 1 mM dithiothreitol) containing 5%
glycerol, protease inhibitor mixture (Roche) and 5 lg of glutathione
S-transferase (GST)-fused p21-binding domain (PBD) of p21 activated
kinase 1 (PAK) (GST-PAK-PBD, Cytoskeleton, Denver, CO). After
centrifugation at 12000 · g for 5 min at 4 C, the supernatant was
incubated with 20 ll of Glutathione Sepharose 4B (GE-Healthcare
Bio-Sciences, Piscataway, NJ) for 30 min at 4 C. The beads were
washed three times with 500 ll of ice-cold buﬀer A and then boiled
in SDS sample buﬀer. Rac1 associated with GST-PAK-PBD and total
Rac1 in cell lysates were detected with anti-Rac1 antibody by Western
blotting.2.6. Other procedures
Immunoprecipitation and Western blotting were performed as de-
scribed previously [15].
Fluorescence microscopy was carried out as described previously
[15].3. Results and discussion
3.1. DGKc selectively interacts with b2-chimaerin in response to
EGF
We have previously demonstrated using a DGK inhibitor
and kinase-dead- and constitutively active-mutants of DGKc
that DGKc acts as an upstream suppressor of Rac1, suppress-
ing lamellipodium/membrane ruﬄe formation in NIH3T3
ﬁbroblasts stimulated with PDGF [15]. To validate this more
convincingly, we silenced DGKc expression in NIH3T3 cells
by transfecting siRNA that speciﬁcally targets DGKc mRNA.
Successful silencing was conﬁrmed by RT-PCR 48 h after
transfection (Fig. 1A). The siRNA-mediated knockdown of
DGKc signiﬁcantly enhanced the PDGF-dependent increase
of the Rac1-GTP level in comparison with the control trans-
fection (Fig. 1B), further indicating that DGKc serves as a
Rac1 suppressor. However, the molecular mechanism underly-
ing the regulation of Rac1 by DGKc remains unknown. In this
context, b2-chimaerin, a Rac-speciﬁc GAP [4,5], was recently
reported to regulate growth factor (EGF)-induced Rac1 activ-
ity using HeLa and COS7 cells overexpressing b2-chimaerin
[14]. We therefore investigated whether the knockdown of
b2-chimaerin, which is expressed in NIH3T3 cells (Fig. 1A), af-
fects Rac1 activity. The b2-chimaerin-speciﬁc siRNA success-
fully depleted the b2-chimaerin expression (Fig. 1A) and,
moreover, markedly augmented the PDGF-dependent increase
of the Rac1-GTP level (Fig. 1B). The siRNAs for DGKc and
b2-chimaerin failed to reciprocally decrease the mRNA levels
of b2-chimaerin and DGKc, respectively (data not shown).
Thus, these results indicate that both DGKc and b2-chimaerin
are critically involved in the regulation of Rac1 activity in
NIH3T3 cells.
Since it was already reported that b2-chimaerin is activated
in vitro by PA [10], the reaction product of DGK, we hypoth-
esized that this GAP is a candidate molecule for linking func-
tionally DGKc with Rac1. First, we attempted to determine
whether DGKc associates with a signaling complex containing
the chimaerin isoform in NIH3T3 cells. For this purpose,
Fig. 1. Endogenous DGKc and b2-chimaerin aﬀect Rac1-GTP levels
in NIH3T3 cells stimulated with PDGF. NIH3T3 cells were transfec-
ted with siRNA targeting EGFP (control), DGKc or b2-chimaerin.
After 48 h of transfection, cells were used for RT-PCR (A) or serum-
starved for 5 h and stimulated with 50 ng/ml PDGF-BB for 5 min (B).
(A) The mRNA levels of DGKc, b2-chimaerin and b-actin were
assayed by RT-PCR. (B) Rac1-GTP precipitated with GST-PAK-PBD
and total Rac1 in cell lysates were detected by Western blotting using
anti-Rac1 antibody and quantiﬁed by densitometry. Upper panels,
representative results of Western blot analysis are shown. Bottom
panel, relative Rac1-GTP levels are shown as the means ± S.D. of
three independent experiments. Rac1-GTP levels in unstimulated cells
transfected with the control siRNA are set at 100. Statistical
signiﬁcance was determined using student’s t-test (*, P < 0.05; **,
P< 0.01).
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However, most of NIH3T3 cells expressing both proteins were
detached from culture dishes. In the following experiments, we
therefore used COS7 cells, which more strongly adhere to cul-
ture dishes. Because COS7 cells express EGF receptor instead
of PDGF receptor, the cells were stimulated with EGF. When
DGKc was immunoprecipitated with anti-DGKc antibody,
b2-chimaerin was clearly co-precipitated (a 2.5-fold increase
at 2 min after EGF-stimulation) in EGF-stimulated COS7 cells
(Fig. 2A and B). Moreover, the interaction occurred rapidly,
reaching a maximum by 2 min after EGF-stimulation, and
returned to the basal level within 10 min (Fig. 2A). The speci-
ﬁcity of the association was conﬁrmed by reverse co-immuno-
precipitation (Fig. 2C). On the other hand, band intensities of
other chimaerin isoforms, a1 and a2, co-immunoprecipitated
were much less than that of b2-chimaerin (Fig. 2D), indicating
that DGKc preferentially binds to b2-chimaerin. Although we
thoroughly examined more than ten cell lines including COS7
and NIH3T3 cells, our antibody, which could clearly detectb2-chimaerin protein overexpressed, failed unfortunately to
detect the cellular b2-chimaerin protein. Thus, we could not
analyze the interaction between endogenous DGKc and b2-
chimaerin.
We next determined whether other type I DGKs bind to b2-
chimaerin. As shown in Fig. 2E, the interaction of DGKa with
b2-chimaerin was markedly weaker than that of DGKc. Be-
cause, for an unknown reason, the expression level of DGKb
was quite low in cDNA-transfected cells, we could not analyze
the interaction with this isozyme. However, these results collec-
tively indicate that DGKc selectively interacts with b2-chima-
erin and that the interaction is dynamically regulated by the
EGF signaling pathway.3.2. DGKc is co-localized with b2-chimaerin in response to EGF
and enhances b2-chimaerin translocation to the plasma
membrane
As an independent test to determine if DGKc interacts with
b2-chimaerin, we assessed whether these proteins co-localize in
COS7 cells. COS7 cells co-expressing DsRed-monomer-tagged
b2-chimaerin and EGFP-tagged DGKc were treated with
EGF for 2 min. Cell stimulation with EGF clearly induced
translocation of DGKc to the plasma membrane (Fig. 3A).
Quantitative analysis exhibited that EGF induced a 3.5-fold
increase in the number of cells exhibiting a distinct transloca-
tion of DGKc to the plasma membrane (Fig. 3B). The trans-
location of DGKc is likely caused by DAG produced by
EGF stimulation in view of the enzyme translocation induced
by phorbol myristate acetate, a potent analog of DAG [19]. In
non-stimulated cells, b2-chimaerin was distributed diﬀusely
throughout the cytoplasm (Fig. 3, A and C). EGF-stimulation
apparently induced translocation of b2-chimaerin to the plas-
ma membrane (Fig. 3C) as already reported [14]. Interestingly,
co-expression of DGKc further enhanced the b2-chimaerin
translocation to the plasma membrane, resulting in the co-
localization of b2-chimaerin with DGKc itself at the mem-
branes (Fig. 3C). On the other hand, the expression of b2-
chimaerin did not aﬀect the extent of DGKc translocation in-
duced by EGF (data not shown). These results indicate that
DGKc associates with a signaling complex containing b2-
chimaerin in vivo, and further suggest that DGKc participates
in the recruitment of b2-chimaerin to the plasma membrane.3.3. DGKc enhances GAP activity of b2-chimaerin in response to
EGF
We reasoned that DGKc associated with a signaling com-
plex containing b2-chimaerin regulates the local PA concentra-
tion, leading to the control of b2-chimaerin activity. To
determine whether DGKc aﬀects the Rac-GAP activity of
b2-chimaerin, COS7 cells co-expressing 3 · FLAG-tagged b2-
chimaerin and EGFP-tagged DGKc were stimulated with
EGF, and GTP-bound (active) Rac1 was detected by pull
down assay. Intriguingly, DGKc signiﬁcantly attenuated the
EGF-dependent Rac1 activation when co-expressed with b2-
chimaerin (Fig. 4A). However, DGKc exerted no eﬀect on
the Rac1-GTP level without b2-chimaerin co-expressed. More-
over, in unstimulated cells, DGKc did not aﬀect Rac1 activa-
tion in spite of its co-expression with b2-chimaerin. These
results indicate that DGKc inhibits EGF-induced Rac1 activa-
tion through enhancing b2-chimaerin Rac-GAP activity
in vivo.
Fig. 2. EGF-induced interaction of DGKc with b2-chimaerin. COS7 cells were co-transfected with plasmids as indicated. After 24 h of transfection,
cells were serum-starved for 15 h and then stimulated with 100 ng/ml EGF for the indicated times. (A, B) COS7 cells were co-transfected with
plasmids encoding myc-tagged DGKc and 3 · FLAG-tagged b2-chimaerin and stimulated with EGF for the indicated times. Myc-tagged DGKc in
cell lysates was immunoprecipitated (IP) with anti-DGKc. Normal rabbit IgG was used as a negative control. (A) Co-precipitation of 3 · FLAG-
tagged b2-chimaerin was detected by Western blotting (WB) using anti-FLAG antibody. Cell lysates (Input) were also subjected to Western blot
analysis using anti-FLAG and anti-myc antibodies. (B) The visualized bands of co-precipitated 3 · FLAG-tagged b2-chimaerin were quantiﬁed by
densitometry. Relative intensity of the interaction is shown as the means ± S.D. of three independent experiments. (C–E) COS7 cells were co-
transfected with plasmids encoding (C) 3 · FLAG-tagged DGKc and either ECFP alone or ECFP-tagged b2-chimaerin, (D) myc-tagged DGKc and
either 3 · FLAG-tagged b2-, a1- or a2-chimaerin, and (E) 3 · FLAG-tagged b2-chimaerin and either EGFP alone (v), EGFP-tagged DGKc or
EGFP-tagged DGKa, and cells were stimulated with EGF for 2 min. (C) ECFP and ECFP-tagged b2-chimaerin were precipitated with anti-GFP
antibody. (D) Myc-tagged DGKc was precipitated with anti-DGKc antibody. (E) EGFP and EGFP-tagged DGKs were precipitated with anti-GFP
antibody. Co-precipitation of 3 · FLAG-tagged protein was detected by Western blotting using anti-FLAG antibody. Cell lysates (Input) were also
subjected to Western blot analysis (WB) using anti-FLAG, anti-myc and anti-GFP antibodies as indicated.
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Fig. 3. Co-localization of DGKc with b2-chimaerin in response to EGF. COS7 cells grown on ﬁbronectin-coated glass coverslips were co-transfected
with plasmids encoding DsRed-monomer-tagged b2-chimaerin and either EGFP or EGFP-tagged DGKc. After 24 h, cells were serum-starved for
5 h and incubated with or without 100 ng/ml EGF for 2 min. Cells were ﬁxed with 3.7% formaldehyde and observed by confocal laser scanning
microscopy. (A) EGFP- and DsRed-monomer-fusion proteins are shown in green and red, respectively. Scale bar = 20 lm. (B, C) The percentages of
cells exhibiting translocation of EGFP-tagged DGKc (B) and DsRed-monomer-tagged b2-chimaerin (C) to the plasma membrane were scored. More
than 25 cells expressing both EGFP- and DsRed-monomer-fusion proteins were counted in each experiment. The results are the means ± S.D. of four
independent experiments. Statistical signiﬁcance was determined using student’s t-test (*, P < 0.05; **, P< 0.01).
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GAP activity by DGKc is dependent on the catalytic activity
of this isozyme, COS7 cells co-expressing 3 · FLAG-tagged
b2-chimaerin and either EGFP-tagged DGKc-WT or EGFP-
tagged DGKc-G494D, a kinase-dead mutant, were treated
with EGF. DGKc-WT signiﬁcantly inhibited the EGF-depen-dent increase of the Rac1-GTP level as observed in Fig. 4A,
whereas DGKc-G494D did not inhibit the Rac1 activation
(Fig. 4B), indicating that the catalytic activity of DGKc is
essential for regulating b2-chimaerin Rac-GAP activity
in vivo. However, in EGF-treated cells, the kinase-dead DGKc
still interacted with b2-chiamerin and enhanced the membrane
Fig. 4. Eﬀects of DGKc and b2-chimaerin on Rac1-GTP levels in cells
stimulated with EGF. COS7 cells were co-transfected with plasmids
encoding (A) 3 · FLAG-tagged b2-chimaerin and either EGFP or
EGFP-tagged DGKc-WT, and (B) 3 · FLAG-tagged b2-chimaerin
and either EGFP, EGFP-tagged DGKc-WT or EGFP-tagged DGKc-
G494D, as indicated. After 24 h, cells were serum-starved for 5 h and
incubated with or without 100 ng/ml EGF for 10 min. Rac1-GTP
precipitated with GST-PAK-PBD and total Rac1 in cell lysates were
detected by Western blot analysis using anti-Rac antibody and
quantiﬁed by densitometry. Cell lysates were also subjected to Western
blot analysis using anti-GFP and anti-FLAG antibodies. Upper
panels, representative results of Western blot analysis are shown.
Bottom panel, relative Rac1-GTP levels are shown as the
means ± S.D. of four independent experiments. In this case, the
Rac1-GTP levels in unstimulated cells transfected with p3 · FLAG-
tagged b2-chimaerin and pEGFP are set at 100. Statistical signiﬁcance
was determined using student’s t-test (*, P < 0.05; **, P< 0.01).
556 S. Yasuda et al. / FEBS Letters 581 (2007) 551–557translocation of the GAP to almost the same extent as did the
WT enzyme (data not shown). Therefore, these data led us to
speculate that translocation of b2-chiamerin to the plasmamembrane alone is not enough to activate this protein. It is
thus quite likely that DAG consumption or PA production
in the signaling complex catalyzed by DGKc in a topologically
restricted manner is critically involved in the elevation of b2-
chimaerin activity in vivo. DAG is known to directly bind to
and induce a conformational change of b2-chimaerin, leading
to an open (active) state [8]. However, because DGK consumes
DAG, it seems unlikely that DAG is a key element for b2-
chimaerin activation induced by DGKc. Worthy of note is
that Caloca et al. recently reported that acidic phospholipids,
especially PA, augmented b2-chimaerin activity in vitro [10].
Hence, it is possible that DGKc activates b2-chimaerin largely
through PA produced by its catalytic activity.
It was recently reported that DAG liberated by phospholi-
pase Cc in response to EGF stimulation plays an important
role in b2-chimaerin activation in vivo [14]. This observation
is not in conﬂict with our present results, because it is possible
to speculate that when an excess amount of DAG is released,
DAG can be utilized by DGKc resulting in a PA production
that may cause a synergistic activation of b2-chimaerin in
cooperation with DAG. Alternatively, PA generated by
DGKc may activate b2-chimaerin more eﬀectively than
DAG, which is considered to simply serve as a precursor of
PA. This notion is supported by the result that, in contrast
to PA, phorbol ester, the more potent DAG analog, did not
activate b2-chimaerin in vitro [10].
In the experiments determining b2-chimaerin GAP activity
(Fig. 4), we noted that the inhibitory eﬀect of DGKc on the
Rac1-GTP level became evident at 5 min and thereafter of
EGF stimulation (data not shown) despite the rapid associa-
tion (within 2 min) of the two proteins (Fig. 2A). The reason
for such delayed activation of b2-chimaerin remains unknown,
but this may be due to complex (time-consuming) regulatory
mechanisms governing its GAP activity, which consist of
DAG production by phospholipase C, the interaction with
DGKc, the recruitment to the plasma membrane, the PA gen-
eration by DGKc and other unknown factors.
Yakubchyk et al. recently reported that DGKf interacts
with and activates Rac1 in neuronal cells [20]. Moreover,
Luo et al. [21] suggested that the Rac1 activation by DGKf
is mediated by PIP5K activation, which may mediate dissocia-
tion of the Rac–Rho guanine nucleotide dissociation inhibitor
complex and/or stimulate nucleotide exchange (GDP–GTP)
[22]. Of interest, DGKc has the opposite eﬀect of DGKf on
the Rac1 activity utilizing a diﬀerent pathway involving b2-
chimaerin instead of PIP5K. These results further support
the paradigm that individual DGK isozymes are assembled
with diﬀerent proteins, thus having functions distinct from
each other.3.4. Concluding remarks
In the present study, we demonstrate that in EGF-stimu-
lated cells, DGKc is capable of negatively regulating Rac1
activity through aﬀecting the intracellular distribution and
GAP activity of b2-chimaerin. These results suggest that
DGKc is a novel regulator of b2-chimaerin, and we thus pro-
pose that b2-chimaerin is a Rac regulator acting as a nexus be-
tween DGKc and Rac1.
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